3 days popular7 days popular1 month popular3 months popular

Study Finds Combined Dopamine Dysfunction In Drug Addicted, Schizophrenic Patients

in one area of the brain’s is increased in schizophrenia, whereas drug is associated with decreased dopamine in a neighboring striatal region. Since substance use disorders often occur concurrently with other mental illnesses, such as schizophrenia, a new NIDA-funded study examined amphetamine-induced dopamine release in patients with comorbid schizophrenia and .

In this study, dopamine release was reduced in the striatum of comorbid patients exposed to amphetamine, yet patients showed enhanced positive symptoms (i.e., ), as previously observed in schizophrenia. These results suggest that these comorbid patients suffer from a combined :

  1. increased dopamine sensitivity in the part of the striatum responsible for the psychotic symptoms and, based on prior research
  2. reduced sensitivity to dopamine in the area of the striatum associated with reward

Such a set of alterations in dopamine release could set up a vicious cycle of using drugs to self-medicate, which in turn may cause or further worsen psychosis.

Better understanding of the brain changes underlying comorbid disorders could lead to improved treatments for both drug addiction and schizophrenia in patients possessing both disorders. This is a vital research area, since failure to treat co-occurring conditions can jeopardize a patient’s chance of recovery.


For a copy of the article abstract, go to: http://www.nature.com/mp/journal/vaop/ncurrent/abs/mp2012109a.html. For more information about comorbid addiction and other mental illnesses, go to http://www.drugabuse.gov/publications/research-reports/comorbidity-addiction-other-mental-illnesses/letter-director.

National Institute on Drug Abuse